TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/16/19 21:12 | 9/13/19 | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gibson Karen | CA | O | SVP,IS,B | S.a | -306 | 67.52 | 0 | -5 | -86 | 1 | D | ||||||||||||||
9/13/19 20:01 | 9/11/19 | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gibson Karen | CA | O | SVP,IS,B | S.edm | -1,052 | 55.74 | 0 | -19 | -96 | 1 | D | ||||||||||||||
2/27/19 20:11 | 2/25/19 | QDEL | Quidel Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gibson Karen | CA | O | SVP,IS,B | S.dm | -1,065 | 66.57 | 0 | -16 | -76 | 5 | D | ||||||||||||||
4/29/08 13:30 | 4/25/08 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Karen | CA | O | CIO | S.d | -633 | 91.15 | 0 | -7 | -68 | 3 | D | ||||||||||||||
2/29/08 14:32 | 2/27/08 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Karen | CA | O | CIO | S.d | -1,240 | 87.00 | 0 | -14 | -58 | 10 | D | ||||||||||||||
2/27/08 20:21 | 2/25/08 | IVGN | Invitrogen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Gibson Karen | CA | O | CIO | S | -104 | 85.20 | 0 | -1 | -11 | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |